Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2-Reference-Cited by-同舟云学术

Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2

Published:2011-12-02 Issue:1 Volume:158A Page:24-41
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Blakeley Jaishri O.,Evans D. Gareth,Adler John,Brackmann Derald,Chen Ruihong,Ferner Rosalie E.,Hanemann C. Oliver,Harris Gordon,Huson Susan M.,Jacob Abraham,Kalamarides Michel,Karajannis Matthias A.,Korf Bruce R.,Mautner Victor-Felix,McClatchey Andrea I.,Miao Harry,Plotkin Scott R.,Slattery William,Stemmer-Rachamimov Anat O.,Welling D. Bradley,Wen Patrick Y.,Widemann Brigitte,Hunter-Schaedle Kim,Giovannini Marco

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference115 articles.

1. Intracranial meningiomatosis causing foster kennedy syndrome by unilateral optic nerve compression and blockage of the superior sagittal sinus;Acebes;J Neuroophthalmol,2009

2. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma);American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC;Otolaryngol Head Neck Surg,1995

3. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma;Ammoun;Neuro Oncol;,2010

4. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors;Ammoun;Nat Rev Neurol;,2011

5. Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2;Ammoun;Neuro Oncol;,2011

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auditory brainstem implants: an analysis of adverse events in the MAUDE database;Neurochirurgie;2024-09

2. Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours;Oncogene;2024-08-23

3. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients;Neuro-Oncology;2024-05-02

4. Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience;Cancers;2024-04-12

5. Case Report: Contralateral Progression of a Vestibular Schwannoma After Resection in a Patient with Neurofibromatosis Type 2;NEUROSURG PRACT;2024